Instructions to Authors
Aims and Scope
The Archives of Rheumatology is an official journal of the Turkish League Against Rheumatism (TLAR) and is published quarterly in March, June, September and November. The target audience of the Archives of Rheumatology includes physiatrists, internists, rheumatologists and primary care physicians interested in rheumatology practice. It publishes original work on all aspects of rheumatology and disorders of connective tissue. The aim of the Archives of Rheumatology is to publish high quality original research articles. In addition to research articles, brief reports, reviews, editorials, letters to the editor and case presentations are also published. It is an independent peer-reviewed international Journal printed in English. Manuscripts are refereed in accordance with a "double-blind peer reviewed" process for both referees and authors.
Editorial Board of the Archives of Rheumatology works under the principles of The World Association of Medical Editors (WAME), the International Council of Medical Journal Editors (ICMJE), and Committee on Publication Ethics (COPE).
Instructions for Authors
Manuscripts in the form of clinical, experimental and drug investigations involving human subjects should be approved by the appropriate local ethics committee and should be performed in accordance with the Helsinki Declaration, revised 2008. Additionally relevant informed consent should be obtained from all subjects prior to study and it should be stated clearly in the "Materials and Methods" section. Any research about animal experiments must follow the "The guide for the care and use of laboratory animals" and should include a clear statement of it. Authors are required to declare the statement on conflict of interests and terms of financial support.
An ORCID ID is required for all authors during the submission of the manuscript. The ID is available at http://orcid.org with free of charge.
The editor reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. They can make corrections without changing the main text.
The author assures that the manuscript is an original work that has not been previously published and is not currently submitted to any other publication. Only those that presented at scientific meetings in the form of abstracts that do not exceed 300 words can be accepted for consideration, if notification of the scientific conference is made. The author should attach the documents showing all relevant permissions to publish quotations, text, tables, or illustrations from copyrighted sources. The author and the co-authors should sign the statement which accepts full responsibility for the accuracy of all content.
All manuscripts are reviewed by the editor and/or associate editors and by at least two independent reviewers. For rejected manuscripts, return of the original illustrations or photographs is not applicable unless notified by the author.
The manuscript format should be in accordance with Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication (http:/www.icmje.org)
1. General Guidelines
Manuscripts can only be submitted online at www.archivesofrheumatology.org. The manuscript text should be written with Calibri, 12 font size in the "Microsoft® Word" program and should be double-spaced. Margins should be ample, with at least 3 cm of space on both sides. Pages should be numbered consecutively, starting with title page as "1" at right bottom corner. Manuscript files should be blinded. The main text should not contain any information about the author's name and affiliation.
The full term for which an abbreviation stands should precede the abbreviation's first use in the text in brackets and the use of standard abbreviations listed in the "Scientific Style and Format" is advocated.
Scientific research articles should include the following sections: title page, abstract, key words, main text (introduction, materials and methods, results, discussion), acknowledgements and references. Articles should not exceed 5000 words and 50 references.
Review articles should include a title, abstract, keywords, main topics and references. It should not exceed 5000 words and more than 150 references. We usually publish solicited reviews, whereas unsolicited review papers would also be considered for publication upon editorial approval.
Case reports should include title, abstract, key words, introduction, case, discussion and references. It should be limited to 1000 words and 20 references. It should be supported by illustrations and photographs.
Editorials are primarily solicited by the Editor, but brief commentaries (500-750 words) can be submitted for consideration.
Letters to the Editor
Brief letters or notes to the Editor regarding published material or information of timely interest are accepted for publication. A letter must not exceed 500 words in length They should not have abstracts. Letters that do not meet these specifications will be returned unreviewed. Letters will be published on a space-available basis. The editor might also choose to invite response from the authors of the original paper. Additionally, any short paper in the format of a "Letter to the Editor" are also welcome.
2. Title Page / Cover Letter
The title page and cover letter are generated automatically during the online submission process. There is no need to prepare and upload them separately. In additon to the title, a running title of the manuscript (not more than 40 characters including spaces) should be entered. In the section for the cover letter, authors should state that there is no conflict of interest associated with the manuscript. In the event of a conflict of interest for any of the authors, please provide a disclosure of interest by giving a detailed explanation.
Original articles should have a structured abstract including the following subheads: Objective, Materials and Methods, Results and Conclusions. For case reports, the structured abstract is not used. Limit the abstract to 300 words. Abbreviations should be avoided. References, tables and citations should not be used in an abstract.
Authors must include relevant keywords (2-5) on the line after the end of the abstract. Use appropriate subject headings as listed in www.nlm.nih.gov/mesh/MBrowser.html.
5. Tables / Graphs / Illustrations / Photograph
Tables, graphs, figures and illustrations should not be placed in the main text. Separate files should be prepared for tables (each table on separate page), graphs, figures and illustrations. Please supply the electronic files for all figures and illustrations including photographs as gif or jpg images with a minimum resolution of 300 dpi.
Each table and figure should have a self-explanatory title and be numbered in order of their citation in the text. Arabic numbers should be prefered for tables, graphs, figures and photographs. Also, each legend should describe clearly what the illustration shows and what each abbreviation means. Tables should not repeat the data of the text. In the case of the use of a previously published table, figure or illustration, written permission from the publisher should be submitted with the manuscript. Identifying information including names, initials, hospital numbers and pedigrees should not be written. Information or illustrations must not permit identification of patients, and written informed consent for publication must be sought for any photograph.
Unpublished observations and submitted manuscripts should not be given in the references section. They must be cited in the text as "name(s), unpublished data, 19..."
Number references in the order in which they are mentioned in the text; do not alphabetize. In the text, author's citations must be followed by reference number in parenthesis. At the end of the text, identify references with Arabic numbers in the text and abbreviate the names of journals in accordance with the Index Medicus (www.nlm.nih.gov/tsd/serials/lji.html). In the reference, the names of all authors should be stated if less than six. Otherwise, after six names, it should be followed by "et al." Examples related to correct use of references are given below.
Standard Journal Article
Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994;37:1593-601.
Guttman L. Spinal cord injuries: comprehensive management and research. 2nd ed. London: Blackwell Scientific Publications; 1976. p. 353-4.
Chapter in Book
Zvaifler NJ. Antimalarials. In: McCarty DJ, editor. Arthritis and allied conditions. 10th ed. Philadelphia: Lea and Febiger; 1985. p. 497-501.
Bengtsson S, Solheim BG. Enforcement of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Reinhoff O, editors. MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; September 6-10, 1992; Geneva, Switzerland. North-Holland; 1992. p. 1561-5.
Morse SS. Factors in the emergence of infectious disease. Emerg Infect Dis [serial online] 1995 1(1):[24 screens]. Available from: http://www/cdc/gov/ncidoc/EID/eid.htm.
"The CONSORT Statement is an evidence-based, minimum set of recommendations for reporting RCTs. It offers a standard way for authors to prepare reports of trial findings, facilitating their complete and transparent reporting, and aiding their critical appraisal and interpretation. The CONSORT Statement comprises a 22-item checklist and a flow diagram, along with some brief descriptive text. The checklist items focus on reporting how the trial was designed, analyzed, and interpreted; the flow diagram displays the progress of all participants through the trial." (www.consort-statement.org).
More information on the CONSORT statement:
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010 Mar 24;8:18.
Authors accept full responsibility for the accuracy of all content, including findings, citations, quotations and references contained within the manuscript. Copyright assignment is a condition of publication and papers will not be passed to the publisher for production unless copyright has been assigned. All authors will be required to assign the copyright transfer form after acceptance of the manuscript.
Turkish League Against Rheumatism. All rights reserved. The Archives of Rheumatology is published using the open access model. All content is available free of charge without restrictions from the journal's website at: www.archivesofrheumatology.org.
The Archives of Rheumatology employs a plagiarism detection program. By submitting your manuscript to the Archives of Rheumatology you accept that your manuscript may be screened for plagiarism against previously published works.
Scientific and legal responsibilities pertaining to the papers belong to the authors. The Contents of the manuscripts and accuracy of references along with the copyright authority of the figures and tables are also the author's responsibility. Neither The Turkish League Against Rheumatism, the Editor, the Editorial Board nor the publisher accept any responsibility for the articles.
The Archives of Rheumatology is freely delivered to all physicians in the Rheumatology and Physical Medicine and Rehabilitation fields. For subscription please contact the Turkish League Against Rheumatism. It is online at www.archivesofrheumatology.org. Tables of contents, abstracts and full texts of all articles published since 2000 are free to all readers.
Yaşam Caddesi No: 13/A Neorama Plaza Kat:6 Daire:26 Söğütözü/Ankara, Turkey.
Phone: +90 312 562 13 22
Fax: +90 312 562 13 22
Web Address: www.archivesofrheumatology.org
Permission requests to reproduce copies of articles for non-commercial use may be obtained from the Editorial Office.
Timur EKİZ, MD
E-Mail Address: firstname.lastname@example.org
Levent ÖZÇAKAR, MD, Professor
E-Mail Address: email@example.com
Yazılım Parkı Bilişim Teknolojileri D.O.R.P. Ltd. Şti.
E-Mail Address: firstname.lastname@example.org
Web Address: www.yazilimparki.com.tr